Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-002814
Filing Date
2025-08-12
Accepted
2025-08-12 16:33:33
Documents
6
Period of Report
2025-08-12

Document Format Files

Seq Description Document Type Size
1 6-K zk2533582.htm 6-K 15735
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 15993
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.1 951927
4 EXHIBIT 99.3 exhibit_99-3.htm EX-99.3 149396
5 image0.jpg GRAPHIC 92505
6 image1.jpg GRAPHIC 50940
  Complete submission text file 0001178913-25-002814.txt   1332000
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND Ireland
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND Ireland 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-22320 | Film No.: 251207288
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)